Legend Biotech Corporation
LEGN
$34.70
$0.421.23%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.21% | -14.85% | -14.72% | 53.20% | 27.60% |
| Total Receivables | -20.48% | 109.27% | 61.18% | 139,107.14% | 252.83% |
| Inventory | 23.00% | 30.72% | 24.18% | 81.88% | 87.69% |
| Prepaid Expenses | 1.17% | -43.63% | -34.28% | -78.84% | -29.42% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -80.39% | 63.76% | -65.41% | -72.02% | -71.89% |
| Total Current Assets | -14.28% | -10.52% | -11.66% | 54.45% | 36.27% |
|
|
|||||
| Total Current Assets | -14.28% | -10.52% | -11.66% | 54.45% | 36.27% |
| Net Property, Plant & Equipment | 6.34% | 10.40% | 15.97% | -2.65% | 17.71% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -46.81% | -37.47% | 12.45% | 37.70% | 19.13% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.54% | 27.07% | 20.38% | 73.88% | 126.31% |
| Total Assets | -9.65% | -5.63% | -6.86% | 46.78% | 38.89% |
|
|
|||||
| Total Accounts Payable | 25.90% | 56.68% | 83.30% | 32.45% | -6.80% |
| Total Accrued Expenses | 4.76% | 21.18% | 3.36% | -- | -59.68% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 50.99% | 48.95% | -6.55% | -32.19% | -10.89% |
| Total Finance Division Other Current Liabilities | 40.28% | 155.01% | 147.44% | -52.60% | 11.43% |
| Total Other Current Liabilities | 40.28% | 155.01% | 147.44% | -52.60% | 11.43% |
| Total Current Liabilities | 28.29% | 54.60% | 46.14% | 4.83% | -27.32% |
|
|
|||||
| Total Current Liabilities | 28.29% | 54.60% | 46.14% | 4.83% | -27.32% |
| Long-Term Debt | 7.06% | 7.51% | 7.74% | 7.72% | 7.82% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.01% | 9.45% | -0.90% | 1.97% | 120.42% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -88.88% | -4.47% | 29.08% | 279.41% | 601.00% |
| Total Liabilities | 5.42% | 24.02% | 22.07% | 9.86% | 1.80% |
|
|
|||||
| Common Stock & APIC | 2.23% | 1.97% | 1.92% | 8,017,793.94% | 59.15% |
| Retained Earnings | -11.92% | -25.98% | -22.31% | -- | -53.62% |
| Treasury Stock & Other | -93.66% | 159.69% | -22.34% | -90.41% | 84.15% |
| Total Common Equity | -16.85% | -16.69% | -17.63% | 78.22% | 68.12% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -16.85% | -16.69% | -17.63% | 78.22% | 68.12% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -16.85% | -16.69% | -17.63% | 78.22% | 68.12% |
|
|
|||||